Molecular Therapies

Schneider H, Schneider P (2025)

Publication Type: Authored book

Publication year: 2025

Publisher: Springer Nature

ISBN: 9783031757907

DOI: 10.1007/978-3-031-75790-7_16

Abstract

This chapter describes the development of molecular therapies for X-linked hypohidrotic ectodermal dysplasia (XLHED), the most common ectodermal dysplasia syndrome, and for the cutaneous and ocular manifestations of p63-associated syndromes. Large parts of the text are based on the following previously published journal article by Holm Schneider: “Ectodermal dysplasias: New perspectives on the treatment of so far immedicable genetic disorders”, Front Genet. 13:1000744, doi: 10.3389/fgene.2022.1000744; available under the terms of the Creative Commons Attribution License (CC BY).

Authors with CRIS profile

Holm Schneider Professur für Kinderheilkunde/Experimentelle Perinatalmedizin

Involved external institutions

Université de Lausanne (UNIL) CH Switzerland (CH)

How to cite

APA:

Schneider, H., & Schneider, P. (2025). Molecular Therapies. Springer Nature.

MLA:

Schneider, Holm, and Pascal Schneider. Molecular Therapies. Springer Nature, 2025.

BibTeX: Download